India, Oct. 23 -- The Canadian stock market's benchmark S&P/TSX Composite Index remains firmly down in negative territory Friday afternoon despite regaining a significant portion of the ground it lost... Read More
India, Oct. 23 -- Crude oil prices have catapulted on Friday both due to increasing fears of a fresh, deep and intense U.S.-Iran war as well as the ongoing Houthi-Saudi Arabia conflict. The escalation... Read More
India, Oct. 23 -- In a recent study, researchers analyzed one year of Fitbit data from more than 22,000 adults aged 40 and above to explore the link between walking and neurological diseases. After f... Read More
India, Oct. 23 -- The major European markets closed lower on Friday as largely weak regional PMI data, and concerns about inflation and monetary tightening amid continued rise in oil prices hurt senti... Read More
India, Oct. 23 -- Lycia Therapeutics Inc. (LYCA) a clinical-stage biotechnology company developing treatments for autoimmune, inflammatory, and allergic diseases, said Thursday it priced its upsized i... Read More
India, Oct. 23 -- European stocks are seen opening lower on Friday after U.S. tech shares sold off overnight on concerns over the faltering global AI trade. U.S. equity futures ticked lower due to en... Read More
India, Oct. 23 -- Gold prices have slumped on Friday amid rising inflation worries due to a surge in crude oil prices for the second day due to the potential chances of re-escalation in the U.S.-Iran ... Read More
India, Oct. 23 -- Friday, Immutep Limited (IMMP) announced health-related quality-of-life data from the Phase II EFTISARC-NEO trial evaluating eftilagimod alfa (efti) in combination with pembrolizumab... Read More
India, Oct. 23 -- Humacyte, Inc. (HUMA) announced positive interim results from the Phase 3 V012 trial evaluating its investigational acellular tissue engineered vessel (ATEV) against arteriovenous (A... Read More
India, Oct. 23 -- Avacta Therapeutics (AVCT.L) announced new preclinical data for AVA6103, its investigational FAP-activated exatecan peptide-drug conjugate, demonstrating antitumor activity in HER2-p... Read More